Delporte J P
Service de Pharmacie, Université de Liège.
Rev Med Liege. 1998 May;53(5):279-84.
Amongst medications used in hospitals, antibiotics represent the most expensive therapeutic group; their use is constantly growing. Beyond acquisition costs, antibiotherapy costs must be approached at a broader level, including costs of preparation, administration, efficacy or inefficacy, monitoring, side effects treatment, and long-term costs resulting bacteria resistance. An attempt to cost containment in antibiotherapy can only result from a global, multidisciplinary strategy, with at all levels, as main objectives, the improvement of the quality and effectiveness of treatment adequate relevance of drug selection and therapy assessment.
在医院使用的药物中，抗生素是最昂贵的治疗类别；其使用量在持续增长。除了采购成本，抗菌治疗成本必须从更广泛的层面来考量，包括制备、给药、疗效或无效、监测、副作用治疗以及细菌耐药导致的长期成本。抗菌治疗中的成本控制尝试只能源于一项全面的多学科策略，在各个层面上，以提高治疗质量和有效性、药物选择的适当相关性以及治疗评估作为主要目标。
